Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
D
Dr. Lal PathLabs Ltd
Score 48/100• Decent
Dr. Lal PathLabs Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health94/100
Valuation 20/100 · PB 10.8738
Technical Avoid
1M -5.335% 6M -3.268% 1Y -5.425%
Confidence100%
Low leverage (D/E)No promoter pledge
#286
View details ➜
D
Dr Reddy's Laboratories Ltd
Score 48/100• Decent
Dr Reddy's Laboratories shows potential with a solid business model and growth prospects, but faces challenges in profitability and market sentiment.
Company’s Health86/100
Valuation 40/100 · PB 3.1392
Technical Avoid
1M 4.66% 6M -6.12% 1Y 2.722%
Confidence100%
Low leverage (D/E)No promoter pledge
#287
View details ➜
D
Dhanvantri Jeevan Rekha Ltd
Score 48/100• Risky
Dhanvantri Jeevan Rekha Ltd shows potential in a growing sector, but inconsistent financial performance and valuation concerns warrant caution.
Company’s Health48/100
Valuation 100/100 · PB 0.9916
Technical Avoid
1M -3.92% 6M 13.106% 1Y 15.832%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#288
View details ➜
D
Deccan Health Care Ltd
Score 48/100• Risky
Deccan Health Care Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health54/100
Valuation 100/100 · PB 0.3782
Technical Avoid
1M -10.721% 6M -21.297% 1Y -46.248%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#289
View details ➜
C
Choksi Laboratories Ltd
Score 48/100• Risky
Choksi Laboratories Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health48/100
Valuation 40/100 · PB 3.518
Technical Avoid
1M -9.465% 6M -32.532% 1Y 86.241%
Confidence100%
No promoter pledgeDecent revenue growth
Weak ROEThin margins
#290
View details ➜
C
Chemo Pharma Laboratories Ltd
Score 48/100• Risky
Chemo Pharma Laboratories Ltd presents several risks with limited growth prospects and profitability concerns, making it a risky investment.
Company’s Health59/100
Valuation 80/100 · PB 1.3282
Technical Avoid
1M 6.808% 6M -11.386% 1Y 49.167%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#291
View details ➜
C
Centenial Surgical Suture Ltd
Score 48/100• Risky
Centenial Surgical Suture Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health39/100
Valuation 80/100 · PB 1.2357
Technical Avoid
1M -11.215% 6M -21.857% 1Y -24.991%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#292
View details ➜
B
Broach Lifecare Hospital Ltd
Score 48/100• Risky
Broach Lifecare Hospital Ltd shows potential in a growing sector but faces significant risks and challenges that warrant caution.
Company’s Health82/100
Valuation 80/100 · PB 1.0052
Technical Avoid
1M -8.824% 6M -19.06% 1Y -36.735%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#293
View details ➜
B
Bandaram Pharma Packtech Ltd
Score 48/100• Risky
The stock presents several risks, particularly in growth consistency and valuation, making it a risky investment at this time.
Company’s Health69/100
Valuation 40/100 · PB 3.3797
Technical Avoid
1M 13.937% 6M -22.506% 1Y -33.161%
Confidence100%
No promoter pledge
Weak ROEThin margins
#294
View details ➜
B
Bafna Pharmaceuticals Ltd
Score 48/100• Decent
Bafna Pharmaceuticals has a decent outlook with growth potential, but faces challenges in profitability and market sentiment.
Company’s Health78/100
Valuation 40/100 · PB 4.061
Technical Avoid
1M -26.699% 6M 99.111% 1Y 80.857%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#295
View details ➜
A
Anondita Medicare Ltd
Score 48/100• Risky
Anondita Medicare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
Company’s Health91/100
Valuation 20/100 · PB 33.3618
Technical Momentum
1M 23.529% 6M 149.023% 1Y 149.023%
Confidence100%
No promoter pledgeHealthy profit margins
#296
View details ➜
A
Amerise Biosciences Ltd
Score 48/100• Risky
Amerise Biosciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health50/100
Valuation 100/100 · PB 0.7982
Technical Avoid
1M -9.589% 6M -28.571% 1Y -19.753%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#297
View details ➜
A
Alpa Laboratories Ltd
Score 48/100• Risky
Alpa Laboratories Ltd presents a risky investment due to inconsistent growth and profitability metrics, alongside valuation concerns.
Company’s Health80/100
Valuation 100/100 · PB 0.989
Technical Avoid
1M -9.112% 6M -20.067% 1Y -32.433%
Confidence100%
Low leverage (D/E)No promoter pledge
#298
View details ➜
A
Ajooni Biotech Ltd
Score 48/100• Risky
Ajooni Biotech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
Company’s Health63/100
Valuation 100/100 · PB 0.8722
Technical Avoid
1M -8.333% 6M -20.641% 1Y -42.674%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#299
View details ➜
A
Aarey Drugs and Pharmaceuticals Ltd
Score 48/100• Risky
Aarey Drugs and Pharmaceuticals Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health58/100
Valuation 80/100 · PB 1.3752
Technical Avoid
1M -30.97% 6M 22.864% 1Y 11.95%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#300
View details ➜
Showing 286 to 300 of 301 (21 Pages)